Nesiritide in the initial management of acute decompensated congestive heart failure

Connecticut Medicine

Volumn 72, Issue 9, 2008, Pages 517-524

  Sakr, Antoine ^a,b   Hahn, Peter ^a   Donohue, Thomas ^a   Ghantous, Andre ^a  

^a YALE UNIVERSITY   (United States)

^b Hospital of Saint Raphael   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMERGENCY HEALTH SERVICE; FEMALE; HEART FAILURE; HUMAN; LENGTH OF STAY; MALE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME;

AGED; COMORBIDITY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; TREATMENT OUTCOME;

EID: 54049137305     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hunt SA, Baker DW, Chin MH, et al: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. J Am Coll Cardiol 2001 Dec; 38(7):2101-13
2. Graves EJ, Gillum BS: 1994 Summary: National Hospital Discharge Survey. National Center for Health Statistics. Adv Data. 1996 Oct 3; (278):1-12.
3. Croft JB, Giles WH, Pollard RA, et al: National trends in the initial hospitalization for heart failure. J Am Geriatr Soc 1997; 45:270-275.
4. American Heart Association: 2002 Heart and Stroke Statistical Update. Dallas, Tex.: American Heart Association; 2001. ©2001, American Heart Association.
5. Mair J, Friedl W, Thomas S, Puscendorft B: Natriuretic peptides in assessments of left ventricular dysfunction. ScandJ Clin Lab Invest 1999: 59:132-42.
6. Kazanagra R, Cheng V, Garcia A, et al: A rapid test for the B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study. J Cardiac Failure 2001; 7:21-29.
7. Maisel AS, Krishnaswamy P, Nowak RM, et al for the BNP Multinational Study Investigators: Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure; primary results from the breathing nonproperly (BNP) multinational study. N Engl J Med 2002; 347:161-7.
8. Logeart D, Thabut G, Jourdain P, et al: Predischarge B-type natriuretic peptide assay for identifying patients at high risk of readmission after decompensated heart failure. J Am Coll Cardiol Feb 2004; 43:635-41.
9. Cheng V, Kazanagra R, Garcia A, et al: A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study. JAm Coll Cardiol 2001; 37:386-91.
10. Efron B, Tibshirani ER: Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Statistical Sei 1986; 1(1):57-77.
11. Efron B, Tibshirani ER: An Introduction to the Bootstrap. London: Chapman & Hall; 1994.
12. Publication Committee for the VMAC Investigators (Vasodilation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. JAMA 2002; 287:1531-40.
13. Sackner-Bernstein SJ, Kowalski M, Fox M, et al: Short-term risk of death after treatment with nesiritide for decompensated heart failure: A pooled analysis of randomized controlled trials. JAMA April 20, 2005; 293:1900-5.
14. Sackner-Bemstein JD, Skopicki HA, Aaronson KD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005; 111:1487-91.